2024/1/4
Galli F, Bindo F, Motos A, Fernández-Barat L, Barbeta E, Gabarrús A, Ceccato A, Bermejo-Martin JF, Ferrer R, Riera J, Peñuelas O.
Procalcitonin and C-reactive protein to rule out early bacterial coinfection in COVID-19 critically ill patients
Intensive care medicine, 2023 Oct 18;67(10):e00510-23.
https://link.springer.com/article/10.1007/s00134-023-07161-1
報告人：洪聿琦

2024/1/16
Hayakawa K, Matsumura Y, Uemura K, Tsuzuki S, Sakurai A, Tanizaki R, Shinohara K, Hashimoto T, Hase R, Matono T, Kato H.
Effectiveness of cefmetazole versus meropenem for invasive urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli
Antimicrobial agents and chemotherapy. 2023 Oct 18;67(10):e00510-23.
https://journals.asm.org/doi/full/10.1128/aac.00510-23
報告人：許彣澤

2024/1/23
Velly L, de Abreu MC, Boutolleau D, Cherubini I, Houas E, Aurousseau A, Hausfater P.
Point-of-care multiplex molecular diagnosis coupled with procalcitonin-guided algorithm for antibiotic stewardship in lower respiratory tract infection: a randomized controlled trial
Clinical Microbiology and Infection. 2023 Nov 1;29(11):1409-16.
https://www.sciencedirect.com/science/article/abs/pii/S1198743X23003592
報告人：陳顥

2024/1/30
Walker J, McCarty T, McGwin G, Ordaya EE, Vergidis P, Ostrosky-Zeichner L, Mammadova M, Spec A, Rauseo AM, Perfect J, Messina J.
Description of Cryptococcosis following SARS-CoV-2 infection: A disease survey through the Mycosis Study Group Education and Research Consortium (MSG-19)
Clinical Infectious Diseases: an Official Publication of the Infectious Diseases Society of America. 2023 Sep 15:ciad551-.
https://europepmc.org/article/med/37713207
報告人：劉祐任

2024/2/6
Smith DJ, Gold JA, Chiller T, Bustamante ND, Marinissen MJ, Rodriquez GG, Cortes VB, Molina CD, Williams S, Vazquez Deida AA, Byrd K.
Update on outbreak of fungal meningitis among US residents who received epidural anesthesia at two clinics in Matamoros, Mexico.
Clinical Infectious Diseases. 2023 Sep 22:ciad570.
https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciad570/7280488
報告人：劉家甫

2024/2/20
Van der Moeren N, Zwart VF, van Leest ML, Thijssen M, Groenewegen R, Kuipers-de Heer M, Murk JL, Tjhie JT, Diederen BM, Stohr JJ.
A SARS-CoV-2 and influenza rapid antigen test-based hospital isolation policy awaiting RT-PCR, a prospective observational study.
Clinical Microbiology and Infection. 2023 Dec 1;29(12):1595-9.
https://www.sciencedirect.com/science/article/pii/S1198743X23004731
報告人：謝明傑

2024/2/27
Sansom SE, Gussin GM, Schoeny M, Singh RD, Adil H, Bell P, Benson EC, Bittencourt CE, Black S, Del Mar Villanueva Guzman M, Froilan MC. 
Rapid Environmental Contamination with Candida auris and Multidrug-Resistant Bacterial Pathogens Near Colonized Patients
Clin Infect Dis. 2023 Dec 6:ciad752.
https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciad752/7459886?login=true
報告人：盧姵㚬

2024/3/05
Kinamon T, Dagher M, Park L, Ruffin F, Fowler Jr VG, Maskarinec SA.
Risk factors and outcomes of hematogenous vertebral osteomyelitis in patients with Staphylococcus aureus bacteremia.
Clinical Infectious Diseases. 2023 Nov 1;77(9):1226-33.
https://academic.oup.com/cid/article/77/9/1226/7281861
報告人：張允謙

2024/3/12
Sumner KM, Masalovich S, O'Halloran A, Holstein R, Reingold A, Kirley PD, Alden NB, Herlihy RK, Meek J, Yousey-Hindes K, Anderson EJ.
Severity of influenza-associated hospitalisations by influenza virus type and subtype in the USA, 2010–19: a repeated cross-sectional study.
The Lancet Microbe. 2023 Nov 1;4(11):e903-12.
https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(23)00187-8/fulltext
報告人：楊景涵

2024/3/19
​Williams, O. Martin, Fergus Hamilton, and Richard Brindle.
The Natural History of Antibiotic-Treated Lower Limb Cellulitis: Analysis of Data Extracted From a Multicenter Clinical Trial.
In Open Forum Infectious Diseases (Vol. 10, No. 10, p. ofad488). US: Oxford University Press.
https://academic.oup.com/ofid/article/10/10/ofad488/7286612
報告人：林賢翰 

2024/3/26
​Xiaomeng Feng, Chenjing Qian, Yuping Fan, Jia Li, Jieru Wang, Qingsong Lin, Erlie Jiang, Yingchang Mi, Lugui Qiu, Zhijian Xiao, Jianxiang Wang, Mei Hong, Sizhou Feng.
Is Short-Course Antibiotic Therapy Suitable for Pseudomonas aeruginosa Bloodstream Infections in Onco-hematology Patients With Febrile Neutropenia? Results of a Multi-institutional Analysis.
Clinical Infectious Diseases, Volume 78, Issue 3, 15 March 2024, Pages 518–525.
https://doi.org/10.1093/cid/ciad605
報告人：賴昱錡

2024/4/2
Greco Kinney A, Kovacic Scherrer N, Sarkar S, Jain P, Wen S, Hadique S.
β-Lactams plus doxycycline versus azithromycin for treatment of severe community-acquired pneumonia in critically ill patients
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 12, December 2023, Pages 2816–2823, 
https://doi.org/10.1093/jac/dkad301
報告人：張婉芸

2024/4/9
Miller LG, McKinnell JA, Singh RD, Gussin GM, Kleinman K, Saavedra R, Mendez J, Catuna TD, Felix J, Chang J, Heim L, Franco R, Tjoa T, Stone ND, Steinberg K, Beecham N, Montgomery J, Walters D, Park S, Tam S, Gohil SK, Robinson PA, Estevez M, Lewis B, Shimabukuro JA, Tchakalian G, Miner A, Torres C, Evans KD, Bittencourt CE, He J, Lee E, Nedelcu C, Lu J, Agrawal S, Sturdevant SG, Peterson E, Huang SS.
Decolonization in Nursing Homes to Prevent Infection and Hospitalization.
N Engl J Med. 2023 Nov 9;389(19):1766-1777.
https://doi.org/10.1056/NEJMoa2215254
報告人：朱純正

2024/4/16
Girón-Ortega, J. A., Fernández-Guerrero, R., de Oca Arjona, M. M., Galán-Sanchez, F., Sagastizábal, G. P., Romea, E. M., de Cueto, M., Garcia, M. B., Palacios-Baena, Z., Jorge, S. J., Rodríguez-Baño, J., Retamar-Gentil, P., & NO-BACT Team).
Antibiotic use and outcome in patients with negative blood cultures, a new target population for antimicrobial stewardship interventions: A prospective multicentre cohort (NO-BACT). 
The Journal of infection. 2024 Feb;88(2):95-102.
https://doi.org/10.1016/j.jinf.2023.11.013
報告人：王品軒

2024/4/23
van der Vaart, T. W., Prins, J. M., Goorhuis, A., Lemkes, B. A., Sigaloff, K. C. E., Spoorenberg, V., Stijnis, C., Bonten, M. J. M., & van der Meer, J. T. M.
The Utility of Risk Factors to Define Complicated Staphylococcus aureus Bacteremia in a Setting With Low Methicillin-Resistant S. aureus Prevalence. 
Clinical infectious diseases. 2024 Apr 10;78(4):846-854.
https://doi.org/10.1093/cid/ciad784
報告人：許庭瑞